Patent US4162323A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4162323A Expired / Lapsed US ⏱️ 0.0 years remaining

Antibiotic N-acetyl-dehydro-thienamycin

Assignee: Merck and Co Inc
•
Filing: 1977-04-18
•
Granted: 1979-07-24
•
Expires: 1997-04-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Antibiotic N-acetyl-dehydro-thienamycin is active against both gram-positive and gram-negative bacteria. The antibiotic is produced by growing a species of Streptomyces in suitable fermentation media.

Inventors

  • 👤 Jean S. Kahan

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 08:24
CPC Classifications
C; C07; C07D; C07D477/00; C07D477/10; C07D477/12; C07D477/16; C07D477/20; A; A61; A61P; A61P31/00; A61P31/04; C12; C12P; C12P17/00; C12P17/18; C12P17/182; C12P17/184

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 81 words
The compound having the following structure: ##STR3## or its pharmaceutically acceptable salts wherein the compound has 300 MHz nuclear magnetic resonance characteristic signals having chemical shifts in ppm as 1.29 (d, J=6, CH 3 ); 2.08 ##STR4## 3.10 (d, d, J=12.5, 8.7, 1H of CH 2 C); 3.21 (d, d, J=12.5, 9.5, 1H of CH 2 C); 3.39 (d, d, J=6.0, 2.5, H 6 ); 4.22 (m, H 5 and H 7 ); 6.07 (d, J=13.5, HC═); 7.19 (d, J=13.5, HC═).
Claim 2
Dependent Claim 81 words
The compound having the following structure: ##STR3## or its pharmaceutically acceptable salts wherein the compound has 300 MHz nuclear magnetic resonance characteristic signals having chemical shifts in ppm as 1.29 (d, J=6, CH 3 ); 2.08 ##STR4## 3.10 (d, d, J=12.5, 8.7, 1H of CH 2 C); 3.21 (d, d, J=12.5, 9.5, 1H of CH 2 C); 3.39 (d, d, J=6.0, 2.5, H 6 ); 4.22 (m, H 5 and H 7 ); 6.07 (d, J=13.5, HC═); 7.19 (d, J=13.5, HC═).
Claim 3
Dependent Claim 96 words
A composition comprising an antibacterial effective amount of the compound having the following structure: ##STR5## or its pharmaceutically acceptable salts wherein the compound has 300 MHz nuclear magnetic resonance characteristic signals having chemical shifts in ppm as 1.29 (d, J=6, CH 3 ); 2.08 ##STR6## 3.10 (d, d, J=12.5, 8.7, 1H of CH 2 C); 3.21 (d, d, J=12.5, 9.5, 1H of CH 2 C); 3.39 (d, d, J=6.0, 2.5, H 6 ); 4.22 (m, H 5 and H 7 ); 6.07 (d, J=13.5, HC═); 7.19 (d, J=13.5, HC═) and a non-toxic pharmaceutically acceptable carrier therefore.
Claim 4
Dependent Claim 96 words
A composition comprising an antibacterial effective amount of the compound having the following structure: ##STR5## or its pharmaceutically acceptable salts wherein the compound has 300 MHz nuclear magnetic resonance characteristic signals having chemical shifts in ppm as 1.29 (d, J=6, CH 3 ); 2.08 ##STR6## 3.10 (d, d, J=12.5, 8.7, 1H of CH 2 C); 3.21 (d, d, J=12.5, 9.5, 1H of CH 2 C); 3.39 (d, d, J=6.0, 2.5, H 6 ); 4.22 (m, H 5 and H 7 ); 6.07 (d, J=13.5, HC═); 7.19 (d, J=13.5, HC═) and a non-toxic pharmaceutically acceptable carrier therefore.

References Cited (Backward Citations)

US3950357A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-07-23 1983-01-22 1983-07-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-07-23 1987-01-22 1987-07-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-07-23 1991-01-22 1991-07-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag